ClassID:

92822

C07C235/08 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Recent Application in this class:
#1
20260152468
2026-06-04

NOVEL CERAMIDE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#2
20260132115
2026-05-14

SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

#3
20250197348
2025-06-19

Acid Degradable Solid Lipid Nanoparticles

#4
20250170062
2025-05-29

NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

#5
20250152512
2025-05-15

NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF

#6
20240360076
2024-10-31

NONIONIC SURFACTANTS

#7
20240327336
2024-10-03

ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS

#8
20240226287
2024-07-11

NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING THE SAME

#9
20240218117
2024-07-04

POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES

#10
20240092728
2024-03-21

HYDROXY-SUBSTITUTED SPHINGOLIPIDS

#11
20230218549
2023-07-13

Alkoxy compounds for disease treatment

#12
20230131535
2023-04-27

ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS

#13
20230131121
2023-04-27

BRANCHED DISCRETE PEG CONSTRUCTS

#14
20230097090
2023-03-30

IMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS

#15
20230058226
2023-02-23

CITRONELLOL ALKOXYLATE SURFACTANTS

#16
20220380300
2022-12-01

Alcohol derivatives as Kv7 potassium channel openers

#17
20220289660
2022-09-15

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#18
20220234997
2022-07-28

Methods and Compositions for Pest Control

#19
20220213016
2022-07-07

Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same

#20
20220185768
2022-06-16

Rheology additives based on hydroxylated di-or tri-amides and mixtures therof

#21
20220041957
2022-02-10

GLUCAMIDE-BASED SURFACTANTS

#22
20220024845
2022-01-27

Compounds and methods for delivery of prostacyclin analogs

#23
20210284599
2021-09-16

Amide compounds, pharmaceutical compositions thereof, and methods of using the same

#24
20210077427
2021-03-18

Alkoxy compounds for disease treatment

#25
20210032196
2021-02-04

Alcohol derivatives as KV7 potassium channel openers

#26
20200369827
2020-11-26

POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES

#27
20200317612
2020-10-08

Branched Discrete PEG Constructs

#28
20200207627
2020-07-02

Method for functionalizing carbon nanoparticles and compositions

#29
20200199063
2020-06-25

TRPV1 modulator compounds

#30
20200181057
2020-06-11

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#31
20200172474
2020-06-04

Alcohol derivatives as KV7 potassium channel openers

#32
20200085957
2020-03-19

Lipids for therapeutic agent delivery formulations

#33
20190358170
2019-11-28

Lipids and lipid compositions for the delivery of active agents

#34
20190345091
2019-11-14

Compounds and methods for delivery of prostacyclin analogs

#35
20190256456
2019-08-22

Alcohol derivatives of carboxamides as Kv7 potassium channel openers

#36
20190183816
2019-06-20

Alkoxy compounds for disease treatment

#37
20190085373
2019-03-21

Chemical tools for imaging phospholipase D activity

#38
20190002392
2019-01-03

Method for synthesising partially N-hydroxyethylated tertiary 1,6-hexanediamines

#39
20180370904
2018-12-27

Method for preparing long-chain compound

#40
20180334417
2018-11-22

Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same

#41
20180334416
2018-11-22

Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same

#42
20180297938
2018-10-18

Compounds for targeting drug delivery and enhancing siRNA activity

#43
20180177746
2018-06-28

Alkoxy compounds for disease treatment

#44
20180141891
2018-05-24

COMPOUNDS AND METHODS FOR DELIVERY OF PROSTACYCLIN ANALOGS

#45
20180057455
2018-03-01

Compounds useful as immunomodulators

#46
20180009740
2018-01-11

Methods and compositions for pest control

#47
20170313656
2017-11-02

Branched discrete PEG constructs

#48
20170107203
2017-04-20

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

#49
20170049722
2017-02-23

Alkoxy compounds for disease treatment

#50
20170001950
2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#51
20170000893
2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#52
20160355464
2016-12-08

FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE

#53
20160355455
2016-12-08

Compounds and methods for delivery of prostacyclin analogs

#54
20160317458
2016-11-03

Lipids and lipid compositions for the delivery of active agents

#55
20160130389
2016-05-12

POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES

#56
20160074514
2016-03-17

Lipids for therapeutic agent delivery formulations

#57
20160051505
2016-02-25

Compounds and methods for delivery of prostacyclin analogs

#58
20160030371
2016-02-04

Compounds and methods for delivery of prostacyclin analogs

#59
20160024251
2016-01-28

Thermoresponsive polyesters

#60
20160024044
2016-01-28

Inhibiting neurotransmitter reuptake

#61
20150321996
2015-11-12

AMIDE DENDRIMER COMPOSITIONS

#62
20150291522
2015-10-15

Dendritic core compounds

#63
20150259274
2015-09-17

Compounds and methods for delivery of prostacyclin analogs

#64
20150239825
2015-08-27

Alkoxy compounds for disease treatment

#65
20150203443
2015-07-23

Lipase-stable thickening agent

#66
20150157733
2015-06-11

Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides

#67
20150005374
2015-01-01

Compounds and methods for delivery of prostacyclin analogs

#68
20140377291
2014-12-25

Glycosphingolipids for use in modulating immune responses

#69
20140364649
2014-12-11

Method for producing high-purity ceramide

#70
20140364648
2014-12-11

Ether-amide compounds and preparation and uses thereof

#71
20140329818
2014-11-06

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

#72
20140309273
2014-10-16

Compounds and methods of treating obesity

#73
20140221689
2014-08-07

Perfluoropolyether urethane additives having (meth)acryl groups and hard coats

#74
20140193849
2014-07-10

Glucose-PEG conjugates for reducing glucose transport into a cell

#75
20130330401
2013-12-12

Lipids for therapeutic agent delivery formulations

#76
20130289125
2013-10-31

Methods and compositions for pest control

#77
20130261187
2013-10-03

Compounds and methods for delivery of prostacyclin analogs

#78
20130253038
2013-09-26

Modified single-stranded polynucleotides

#79
20130203855
2013-08-08

Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use

#80
20130197096
2013-08-01

Alkoxy compounds for disease treatment

#81
20130184279
2013-07-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#82
20130137768
2013-05-30

PANTHENYL DOCOSAHEXAENEOATE AND ITS USE FOR TREATING AND PREVENTING CARDIOVASCULAR DISEASES

#83
20130053342
2013-02-28

Hydroxylated amide skin moisturizer

#84
20130052130
2013-02-28

Branched Discreet PEG Constructs

#85
20130046013
2013-02-21

SALICYLATE FATTY ACID DERIVATIVES

#86
20130017249
2013-01-17

Compounds for targeting drug delivery and enhancing siRNA activity

#87
20120328536
2012-12-27

Taste improving substances

#88
20120295980
2012-11-22

Compounds and methods for delivery of prostacyclin analogs

#89
20120283216
2012-11-08

FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES

#90
20120264972
2012-10-18

Poly(meth)acrylamides and poly(meth)acrylates containing flourinated amide

#91
20120232015
2012-09-13

-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents

#92
20120215028
2012-08-23

BIOBASED POLYOL CROSS-LINKERS FOR USE IN PREPARING POLYESTERS AND REVERSIBLE POLYURETHANES

#93
20120214852
2012-08-23

Alkoxy compounds for disease treatment

#94
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#95
20120157523
2012-06-21

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

#96
20120149903
2012-06-14

PROCESS FOR PREPARING AND PURIFYING 3-AMINOPROPANOL

#97
20120142883
2012-06-07

Perfluoropolyether urethane additives having (meth)acryl groups and hard coats

#98
20120129933
2012-05-24

Ceramide dimers and use thereof as pharmaceutical preparation or cosmetic preparation

#99
20120129894
2012-05-24

Alkoxy compounds for disease treatment

#100
20120122938
2012-05-17

Alkoxy compounds for disease treatment

#101
20120108667
2012-05-03

HYDROXY CERAMIDES AND ANALOGS THEREOF AND THEIR USE FOR PREVENTING OR TREATING CANCER

#102
20120095003
2012-04-19

Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof

#103
20120005843
2012-01-12

Mixture of amides and cosmetic compositions comprising said mixture

#104
20110318542
2011-12-29

Fluorine-containing compound, fluorine-containing polymer compound, resist composition and patterning method using same

#105
20110263898
2011-10-27

Ether-amide compounds and preparation and uses thereof

#106
20110251158
2011-10-13

FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE

#107
20110243851
2011-10-06

GLUCOSE-PEG CONJUGATES FOR REDUCING GLUCOSE TRANSPORT INTO A CELL

#108
20110237613
2011-09-29

DHA esters and use thereof in treatment and prevention of cardiovascular disease

#109
20110224324
2011-09-15

Polymerizable photoinitiators and radiation curable compositions

#110
20110213031
2011-09-01

Type I natural ceramide derivative and method for producing same

#111
20110178151
2011-07-21

COMPOUNDS AND METHODS OF TREATING OBESITY

#112
20110124726
2011-05-26

Carboxylic acid derivatives

#113
20110118213
2011-05-19

Compounds and methods for delivery of prostacyclin analogs

#114
20110091525
2011-04-21

Polyethyleneglycol-modified lipid compounds and uses thereof

#115
20110021482
2011-01-27

N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents

#116
20110015416
2011-01-20

METHOD FOR MIXING FLUIDS, METHOD FOR PRODUCING PARTICULATES, AND PARTICULATES

#117
20100292289
2010-11-18

TREATMENT OF METABOLIC SYNDROME WITH NOVEL AMIDES

#118
20100279959
2010-11-04

Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors

#119
20100233419
2010-09-16

Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide

#120
20100160595
2010-06-24

Perfluoropolyether urethane additives having (meth)acryl groups and hard coats

#121
20100145048
2010-06-10

Compounds for the treatment of inflammatory disorders

#122
20100104629
2010-04-29

CATIONIC LIPIDS AND USES THEREOF

#123
20100076055
2010-03-25

Cationic Lipids and Uses Thereof

#124
20100069500
2010-03-18

Amide dendrimer compositions

#125
20100062990
2010-03-11

Pseudoglycolipid and use thereof

#126
20100062472
2010-03-11

BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF

#127
20100055169
2010-03-04

CATIONIC LIPIDS AND USES THEREOF

#128
20100055168
2010-03-04

CATIONIC LIPIDS AND USES THEREOF

#129
20100048651
2010-02-25

Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

#130
20100041794
2010-02-18

HYDROXYL-TERMINATED OR CARBOXYLIC ACID-TERMINATED REACTIVE MONOMER COMPOSITIONS, THEIR PREPARATION AND THEIR USE

#131
20100041717
2010-02-18

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

#132
20100009933
2010-01-14

Hydroxylated amide skin moisturizer

#133
20100004482
2010-01-07

Fluorinated esters

#134
20090326074
2009-12-31

Alkoxy compounds for disease treatment

#135
20090312450
2009-12-17

POLYURETHANES MADE FROM HYDROXYL-CONTAINING FATTY ACID AMIDES

#136
20090312432
2009-12-17

Fluorosurfactants

#137
20090312354
2009-12-17

DHA esters and use thereof in treatment and prevention of cardiovascular disease

#138
20090285881
2009-11-19

CATIONIC LIPIDS AND USES THEREOF

#139
20090263407
2009-10-22

Cationic Lipids and Uses Thereof

#140
20090258887
2009-10-15

Carboxylic acid derivatives

#141
20090227453
2009-09-10

Formulations

#142
20090163557
2009-06-25

Cannabinergic lipid ligands

#143
20090042997
2009-02-12

Fluoroalkyl acid amide surfactants

#144
20080318976
2008-12-25

Alpha-hydroxy amides as bradykinin antagonists or inverse agonists

#145
20080268122
2008-10-30

Flavour modulating substances

#146
20080262083
2008-10-23

ANTIBACTERIAL AGENTS

#147
20080249167
2008-10-09

Compounds and methods for delivery of prostacyclin analogs

#148
20080177050
2008-07-24

Alpha, omega-difunctional aldaramides

#149
20080146768
2008-06-19

PROCESSES FOR PREPARING POLYMERS USING ALPHA,OMEGA-DIFUNCTIONAL ALDARAMIDES

#150
20080108728
2008-05-08

Reactive (meth)acrylate monomer compositions and preparation and use thereof

#151
20080039605
2008-02-14

Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide

#152
20070259089
2007-11-08

Taste improving substances

#153
20070225374
2007-09-27

Hydroxypropyl Amides for the Treatment of Alzheimer's Disease

#154
20070167426
2007-07-19

Compounds for the treatment of inflammatory disorders and microbial diseases

#155
20070155813
2007-07-05

Hsp90 family protein inhibitors

#156
20070105913
2007-05-10

Alkynyl aryl carboxamides

#157
20070082948
2007-04-12

Compounds and methods for delivery of prostacyclin analogs

#158
20070078182
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#159
20070078095
2007-04-05

Compounds and methods for delivery of prostacyclin analogs

#160
20070072854
2007-03-29

Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive

#161
20070066683
2007-03-22

Selective peroxisome proliferator activated receptor modulators

#162
20060264672
2006-11-23

Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers

#163
20060258886
2006-11-16

Alpha, omega-difunctional aldaramides

#164
20060252778
2006-11-09

Compounds for the treatment of inflammatory disorders

#165
20060216524
2006-09-28

Perfluoropolyether urethane additives having (meth)acryl groups and hard coats

#166
20060216500
2006-09-28

Perfluoropolyether urethane additives having (meth)acryl groups and hard coats

#167
20060178366
2006-08-10

Compounds for the treatment of inflammatory disorders

#168
20060122429
2006-06-08

Preparation of optically active amines

#169
20060121583
2006-06-08

Method for synthesizing ceramide-type compounds

#170
20060111406
2006-05-25

Amide linker peroxisome proliferator activated receptor modulators

#171
20060094790
2006-05-04

Use of sphingosine kinase activator as skin disease treating agent and method for treating skin diseases using the same

#172
20060047138
2006-03-02

Antibacterial agents

#173
20050282901
2005-12-22

Compounds and methods for delivery of prostacyclin analogs

#174
20050175682
2005-08-11

Polyethyleneglycol-modified lipid compounds and uses thereof

#175
20050085540
2005-04-21

Compounds and methods for delivery of prostacyclin analogs

#176
20050002972
2005-01-06

Process of making D-panthenyl triacetate